From: The Wnt/β-catenin signalling pathway in Haematological Neoplasms
Factor | Target | Disease | Clinical Trials |
---|---|---|---|
CWP232291 | β-catenin | AML | NCT01398462 [116] |
PRI-724 | CBP/β-catenin | AML/CML | NCT01606579 [117] |
Lawsone | FZD | ALL | [118] |
WNT974 | β-catenin | lymphoma | |
PRMT5 | Wnt/β-catenin and AKT/GSK3β | lymphoma | [121] |
AV-65 | β-catenin | MM | [122] |
DAC/BZM | β-catenin/GSK3β | MM | [123] |
BC2059 | β-catenin | MM | [124] |
panobinostat/Tegavivint | β-catenin | MM | [125] |